Sept. 17, 2025 — Barbara Riegel, Ph.D., R.N., FAHA, Emerita Edith Clemmer Steinbright Professor of Gerontology at the ...
Sept. 16, 2025 — PaceMate has appointed Sean Shoffstall as Head of AI, Innovation and Data Strategy. Shoffstall joins ...
Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating ...
Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable ...
Sept. 2, 2025 — Although cardiovascular disease is a leading cause of death for women, they remain underrepresented in ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Sept. 9, 2025 — The John Ritter Foundation for Aortic Health, a nonprofit dedicated to raising awareness, advancing ...
Sept. 9, 2025 — The American Venous Forum (AVF), International Society on Thrombosis and Haemostasis (ISTH), National ...
Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Sept. 04, 2025 — CorVista Health has published a new case series in the Journal of the American College of Cardiology ...
Sept. 9, 2025 — Neurescue ApS has received CE Mark approval for its Neurescue device, a medical device approved to treat ...
Sept. 8, 2025 — GE HealthCare recently announced a Distribution and Services Agreement (DSA) with CardioNavix, a part of ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Sept. 8, 2025 — Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation ...
Sept. 8, 2025 — AMO Pharma Ltd., a clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders ...
Sept. 5, 2025 — Idorsia Ltd has announced a first-of-its-kind initiative with the Stanford Hypertension Center and Duke ...
September 17, 2025
